Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | President and COO | August 25, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date August 25, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Sale · Disposed 280 · Balance 0 F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. |
| American Depositary SharesSEC Table I · non-derivative | Direct | 12,365 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,365 F1: Each American Depositary Share represents 13 Ordinary Shares. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,270,084 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,270,084 |
| American Depositary SharesSEC Table I · non-derivative | IndirectBy Wife | 4,000 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,000 F1: Each American Depositary Share represents 13 Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 21:12 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 280 | $380.00 | $106,400.00 |
DisclosureSEC source: 0001739452-26-000011 · wk-form4_1787865149.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:15 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,292 | $276.26 | $356,926.89 |
DisclosureSEC source: 0001739452-26-000008 · wk-form4_1782422104.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.23 to $276.475, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:19 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,357 | $266.76 | $361,996.85 |
DisclosureSEC source: 0001739452-26-000007 · wk-form4_1781817585.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.4658 to $266.8575, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 229,775 | $0.00 Strike: $20.81 | $0.00 |
DisclosureSEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · derivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,775 Underlying: Ordinary Shares · 229,775 shares Expires 2036-06-10 F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F5 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 626 | $261.20 | $163,512.26 |
DisclosureSEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.19 to $261.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 118,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001739452-26-000006 · wk-form4_1781560516.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,308,161 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:23 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 40 | $270.55 | $10,822.00 |
DisclosureSEC source: 0001739452-26-000005 · wk-form4_1781126634.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:23 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,444 | $269.33 | $388,916.13 |
DisclosureSEC source: 0001739452-26-000005 · wk-form4_1781126634.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.88 to $269.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 00:12 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 78,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001739452-26-000002 · wk-form4_1773187917.xml · nonDerivative · entry 2 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,216,524 F2 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 00:12 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 168,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001739452-26-000002 · wk-form4_1773187917.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,137,900 F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 10 | $382.32 | $3,823.20 |
DisclosureSEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 826 | $381.19 | $314,862.20 |
DisclosureSEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.115 to $381.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:57 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 3,155 | $380.23 | $1,199,617.45 |
DisclosureSEC source: 0001739452-25-000006 · wk-form4_1763589459.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 836 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,769 | $381.05 | $674,076.92 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 13 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $381.00 to $381.50, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,240 | $380.33 | $1,612,582.66 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 12 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $380.00 to $380.75, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 154 | $362.07 | $55,759.07 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,009 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,846 | $360.10 | $1,745,024.25 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,163 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.00 to $360.945, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 100 | $357.43 | $35,743.18 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,009 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.385 to $357.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 120 | $355.00 | $42,600.00 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,109 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 251 | $354.20 | $88,903.30 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,229 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.59 to $354.585, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 789 | $352.78 | $278,341.29 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,480 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.28 to $353.10, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 3,240 | $351.41 | $1,138,569.05 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,269 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.05 to $351.52, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:35 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 500 | $350.44 | $175,220.50 |
DisclosureSEC source: 0001739452-25-000005 · wk-form4_1763159727.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,509 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 119,340 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 27 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,046 Underlying: Ordinary Shares · 119,340 shares Expires 2034-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F22 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 399,828 | $0.00 Strike: $11.98 | $0.00 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 26 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 309,881 Underlying: Ordinary Shares · 399,828 shares Expires 2032-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F21 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 600 | $308.03 | $184,819.32 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 23 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.99 to $308.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,917 | $307.43 | $1,511,625.93 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 22 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.95 to $307.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 12,232 | $306.26 | $3,746,189.44 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 21 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,517 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.95 to $306.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 8,522 | $305.48 | $2,603,297.15 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 20 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,749 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.95 to $305.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 500 | $304.19 | $152,097.45 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 19 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,271 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.85 to $304.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 6,965 | $303.31 | $2,112,586.19 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 18 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,771 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.79 to $303.68, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 5,800 | $302.04 | $1,751,856.94 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 17 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,736 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.52 to $302.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 400 | $300.86 | $120,345.48 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 16 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,536 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.44 to $301.07, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 9,180 | $159.03 | $1,459,895.40 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 15 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 30,756 | $155.68 | $4,788,094.08 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 14 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 352,105 | $0.00 Strike: $11.98 | $0.00 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 25 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 709,709 Underlying: Ordinary Shares · 352,105 shares Expires 2032-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F21 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 22, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionShare Option (Right to Buy) · Derivative | 296,049 | $0.00 Strike: $13.42 | $0.00 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · derivative · entry 24 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 296,049 shares Expires 2030-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F19 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F20 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 9,617 | $307.38 | $2,956,061.92 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 13 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.20 to $307.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 9,637 | $306.74 | $2,956,093.86 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 12 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,617 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.19 to $307.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 528 | $305.59 | $161,352.26 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 11 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,254 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.17 to $306.13, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 7,359 | $304.37 | $2,239,886.79 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 10 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,782 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.00 to $304.80, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 3,517 | $303.54 | $1,067,564.25 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 9 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,141 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.00 to $303.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 5,800 | $302.45 | $1,754,193.76 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,658 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $302.00 to $302.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 4,500 | $301.49 | $1,356,702.75 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,458 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.00 to $301.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 8,900 | $300.33 | $2,672,961.92 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,958 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2024, as most recently amended on May 14, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $300.99, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 27,085 | $155.68 | $4,216,592.80 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:40 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | Exercise / conversionAmerican Depositary Shares | 22,773 | $174.43 | $3,972,294.39 |
DisclosureSEC source: 0001628280-25-040540 · wk-form4_1755290412.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:08 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 1,363 | $260.00 | $354,380.00 |
DisclosureSEC source: 0001651308-25-000117 · wk-form4_1750885728.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 21:08 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 630 | $250.87 | $158,047.22 |
DisclosureSEC source: 0001651308-25-000112 · wk-form4_1750280880.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 21:08 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 100 | $266.22 | $26,622.00 |
DisclosureSEC source: 0001651308-25-000112 · wk-form4_1750280880.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.